Drug Shortage Report for TARO-BUPROPION XL

Last updated on 2022-11-24 History
Report ID 150071
Drug Identification Number 02475812
Brand name TARO-BUPROPION XL
Common or Proper name BUPROPION
Company Name SUN PHARMA CANADA INC
Market Status MARKETED
Active Ingredient(s) BUPROPION HYDROCHLORIDE
Strength(s) 300MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 500
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2021-09-23
Estimated end date 2022-12-02
Actual end date
Shortage status Actual shortage
Updated date 2022-11-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2022-11-24 French Compare
v17 2022-11-24 English Compare
v16 2022-11-16 French Compare
v15 2022-11-16 English Compare
v14 2022-11-03 French Compare
v13 2022-11-03 English Compare
v12 2022-09-16 French Compare
v11 2022-09-16 English Compare
v10 2022-08-25 French Compare
v9 2022-08-25 English Compare
v8 2022-08-17 French Compare
v7 2022-08-17 English Compare
v6 2022-01-06 French Compare
v5 2022-01-06 English Compare
v4 2021-12-07 French Compare
v3 2021-12-07 English Compare
v2 2021-11-26 French Compare
v1 2021-11-26 English Compare

Showing 1 to 18 of 18